The British pharma giant said Emma Walmsley's current pay could put off candidates for her eventual successor.

UK drugmaker says Emma Walmsley is underpaid compared with global competitors as it abandons diversity targets ...

British drugmaker GSK will no longer set diversity targets, it said on Thursday, as it became the latest company to scale ...

For GSK CEO Emma Walmsley, there was good news and bad news in the company’s annual report. | For GSK CEO Emma Walmsley, ...

One of the lowest paid CEOs in pharma—and one of the only woman leading a top-tier giant—is set to receive up to $27.2 ...

For Big Pharma CEOs, compensation can swing drastically year to year — from base salary to bonus incentives to stock options ...

GSK could double its long-serving CEO Emma Walmsley’s pay packet to £21.6 million ($27.2 million) after admitting its boss's current pay didn’t reward her performance and would put off future ...

GSK plc (LON:GSK – Get Free Report) insider Emma Walmsley sold 38,459 shares of the stock in a transaction dated Monday, February 17th. The stock was sold at an average price of GBX 1,418 ($17.92), ...

While both broadly agreed with the company’s plans to spin off its consumer-health unit, they questioned whether Chief ...

GSK boss Walmsley (left) received £10.6m in salary and bonuses in 2024 while Blanc (right), head of insurance group Aviva, ...